Cellebrite DI Ltd.(CLBT)Earnings, Financials & Key Ratios
CLBT•NASDAQ
$16.57
53.5× P/E·Price updated Jul 7, 2026
SectorTechnologyIndustryInfrastructure SoftwareSub-IndustryData platforms, integration and analytics
AboutCellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions. The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation.Show more
- Revenue$476M+18.6%
- EBITDA$78M+16.0%
- Net Income$78M+127.7%
- EPS (Diluted)0.31+123.0%
- Gross Margin84.2%-0.2%
- EBITDA Margin16.47%-2.1%
- Operating Margin13.98%-1.5%
- Net Margin16.47%+123.3%
- ROE19.1%+112.5%
CLBT Price & Volume
Cellebrite DI Ltd. (CLBT) stock price & volume — 10-year historical chart
Loading chart...
Subscription Transition Drives Recurring Digital Intelligence Growth
Investment Thesis • Updated 2026Q1
VerdictNeutral
Growth:Decelerating
Profitability:Moderate
Financial:Healthy
Cash Flow:Improving
Primary Risk:Geopolitical and regulatory exposure
Key Thesis Takeaways
- Cellebrite is successfully pivoting toward a high-margin, subscription-based digital intelligence model, evidenced by a robust 82.5% gross margin as of 2026Q1.
- While the company has significantly strengthened its equity position to $510.5 million, investors should monitor the deceleration in revenue growth from 26.9% in 2024Q3 to 19.3% in 2026Q1.
- Future performance will likely depend on the company's ability to achieve consistent operating leverage while managing the integration risks associated with its $119.6 million goodwill balance.
Verdict Logic
while the company has improved its financial health with a $510.5 million equity base, the current 44.39 P/E ratio warrants caution given the recent deceleration in revenue growth to 19.3%.
CLBT Growth Metrics
Cellebrite DI Ltd. (CLBT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years19.53%
3 Years20.68%
TTM18.43%
Profit CAGR
10 Years-
5 Years68.41%
3 Years-13.45%
TTM137%
EPS CAGR
10 Years-
5 Years-
3 Years-19.31%
TTM129.82%
Return on Capital
10 Years8.13%
5 Years10.6%
3 Years14.89%
Last Year13.79%
CLBT Recent Earnings
Cellebrite DI Ltd. (CLBT) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
May 14, 2026Metric
Actual
Est
EPS
$0.04-25.6%
$0.05
Rev
$128M+1.0%
$127M
Q1 2026
Feb 11, 2026Metric
Actual
Est
EPS
$0.09-35.7%
$0.14
Rev
$129M+2.1%
$126M
Q4 2025
Nov 12, 2025Metric
Actual
Est
EPS
$0.14+48.2%
$0.09
Rev
$126M+2.5%
$123M
Q3 2025
Aug 14, 2025Metric
Actual
Est
EPS
$0.12+20.0%
$0.10
Rev
$113M+1.0%
$112M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 14, 2026 | $0.04vs $0.05-25.6% | $128Mvs $127M+1.0% |
| Q1 2026 | Feb 11, 2026 | $0.09vs $0.14-35.7% | $129Mvs $126M+2.1% |
| Q4 2025 | Nov 12, 2025 | $0.14vs $0.09+48.2% | $126Mvs $123M+2.5% |
| Q3 2025 | Aug 14, 2025 | $0.12vs $0.10+20.0% | $113Mvs $112M+1.0% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Cellebrite DI Ltd. (CLBT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $16.57 | $4.13B | 53.45 | 18.56% | 16.47% | 19.1% | — | |
| $640.46 | $51.6B | 424.15 | 33.47% | 6.91% | 6.58% | — | |
| $45.84 | $5.38B | -40.57 | 13.17% | -20.71% | -27.37% | — | |
| $14.82 | $555.26M | 7.80 | 0% | 28.47% | 27.31% | — | |
| $42.37 | $3.03B | 32.59 | 4.47% | 11.12% | 5.96% | — | |
| $21.40 | $472.82M | 38.21 | -7.29% | 8.26% | 3.67% | — |
Compare CLBT vs Peers
Cellebrite DI Ltd. (CLBT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when CLBT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CLBT Frequently Asked Questions
Cellebrite DI Ltd. (CLBT) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Cellebrite DI Ltd.'s revenue?
Cellebrite DI Ltd. (CLBT) reported $496.4M in revenue for fiscal year 2025. This represents a 189% increase from $171.9M in 2019.
How fast is Cellebrite DI Ltd. growing?
Cellebrite DI Ltd. (CLBT) grew revenue by 18.6% over the past year. This is strong growth.
Is CLBT profitable?
Yes, Cellebrite DI Ltd. (CLBT) is profitable, generating $71.9M in net income for fiscal year 2025 (16.5% net margin).
Dividend & Returns
What is CLBT's return on equity?
Cellebrite DI Ltd. (CLBT) has a return on equity (ROE) of 19.1%. This is reasonable for most industries.
What is Cellebrite DI Ltd.'s free cash flow?
Cellebrite DI Ltd. (CLBT) generated $154.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.